Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Coursera
COUR
$1.64B
| $18.7M | 0.01% |
1,436,726
+1,352,481
| +1,605% | +$16.2M |
|
1427
Dollar Tree
DLTR
$25.8B
| $18.7M | 0.01% |
130,268
+125,274
| +2,508% | +$18.4M |
|
1428
PUT
Align Technology
ALGN
$11.3B
| $18.6M | 0.01% |
+52,500
| New | +$16.7M |
|
1429
Jack in the Box
JACK
$320M
| $18.5M | 0.01% |
190,088
-106,599
| -36% | -$9.7M |
|
1430
PUT
BP
BP
$110B
| $18.5M | 0.01% |
525,000
+441,800
| +531% | +$16.4M |
|
1431
PUT
Automatic Data Processing
ADP
$112B
| $18.5M | 0.01% |
84,200
-127,000
| -60% | -$27.4M |
|
1432
Autoliv
ALV
$9.08B
| $18.5M | 0.01% |
217,118
-720,820
| -77% | -$62.5M |
|
1433
PUT
Silicon Motion
SIMO
$8.2B
| $18.5M | 0.01% |
+256,800
| New | +$16.4M |
|
1434
Vista Energy
VIST
$7.57B
| $18.4M | 0.01% |
764,119
+289,483
| +61% | +$6.29M |
|
1435
Rio Tinto
RIO
$174B
| $18.4M | 0.01% |
288,682
-440,320
| -60% | -$28.3M |
|
|
AMED
1436
DELISTED
Amedisys
AMED
| $18.4M | 0.01% |
201,342
-188,784
| -48% | -$15.5M |
|
1437
Darling Ingredients
DAR
$9.88B
| $18.4M | 0.01% |
288,586
+219,880
| +320% | +$13.4M |
|
1438
Telephone and Data Systems
TDS
$3.89B
| $18.4M | 0.01% |
2,232,357
+1,224,286
| +121% | +$10.4M |
|
|
SILK
1439
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $18.3M | 0.01% |
564,074
-308,383
| -35% | -$11.3M |
|
1440
PUT
Sysco
SYY
$40B
| $18.3M | 0.01% |
246,600
-21,100
| -8% | -$1.56M |
|
|
MRTX
1441
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $18.3M | 0.01% |
505,309
+486,275
| +2,555% | +$20M |
|
1442
DigitalBridge
DBRG
$2.95B
| $18.2M | 0.01% |
1,238,426
+1,176,329
| +1,894% | +$14.4M |
|
1443
CALL
Moderna
MRNA
$63.4B
| $18.2M | 0.01% |
149,900
-35,300
| -19% | -$4.71M |
|
1444
BCE
BCE
$22B
| $18.2M | 0.01% |
399,263
+336,340
| +535% | +$15.7M |
|
1445
iShares MSCI Brazil ETF
EWZ
$8.23B
| $18.2M | 0.01% |
+561,060
| New | +$16.7M |
|
1446
Aecom
ACM
$8.08B
| $18.2M | 0.01% |
214,804
-662,957
| -76% | -$54.4M |
|
1447
Oxford Industries
OXM
$549M
| $18.2M | 0.01% |
184,765
+124,836
| +208% | +$12.8M |
|
1448
PUT
Norwegian Cruise Line
NCLH
$7.93B
| $18.2M | 0.01% |
834,300
+575,000
| +222% | +$8.8M |
|
1449
O-I Glass
OI
$1.15B
| $18.1M | 0.01% |
849,458
-48,872
| -5% | -$1.05M |
|
1450
CALL
Truist Financial
TFC
$61.4B
| $18.1M | 0.01% |
596,700
-126,400
| -17% | -$3.93M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.